Immunic, Inc. reported unaudited consolidated earnings results for the first quarter ended March 31, 2021. For the quarter, Loss from operations was $32,387,000 against $9,014,000 reported a year ago. Net loss was $34,534,000 against $8,487,000 reported a year ago. Net loss per share, basic and diluted was $1.63 against $0.79 reported a year ago.